During the past two and a half years, we’ve seen unparalleled innovation and private-public collaboration in the global fight against Covid-19. The rapid development and rollout of new vaccines, diagnostic tests, and therapeutics have saved millions of lives. 

However, these developments haven’t benefited everyone equally. Although more than 67 percent of the global population has received at least one dose of the Covid-19 vaccine, disparities between higher and lower income countries are wide. As of May 2022, 72 percent of people in high-income countries have received one dose, compared to 18 percent in low-income countries, according to the United Nations Development Programme’s Global Dashboard for Vaccine Equity.

 …